Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glioblastoma and MiRNAs
Swalih P. Ahmed, Javier S. Castresana, Mehdi Hayat Shahi
Cancers (2021) Vol. 13, Iss. 7, pp. 1581-1581
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

miRNAs role in glioblastoma pathogenesis and targeted therapy: Signaling pathways interplay
Shereen Saeid Elshaer, Ahmed I. Abulsoud, Doaa Fathi, et al.
Pathology - Research and Practice (2023) Vol. 246, pp. 154511-154511
Closed Access | Times Cited: 56
MGMT in TMZ-based glioma therapy: Multifaceted insights and clinical trial perspectives
Rajni Shaw, Malini Basu, Subhajit Karmakar, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2024) Vol. 1871, Iss. 3, pp. 119673-119673
Open Access | Times Cited: 15
Use of microRNAs as Diagnostic, Prognostic, and Therapeutic Tools for Glioblastoma
David Valle‐García, Verónica Pérez de la Cruz, Itamar Flores, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2464-2464
Open Access | Times Cited: 11
Use of Oleuropein and Hydroxytyrosol for Cancer Prevention and Treatment: Considerations about How Bioavailability and Metabolism Impact Their Adoption in Clinical Routine
Francesco Gervasi, Fanny Pojero
Biomedicines (2024) Vol. 12, Iss. 3, pp. 502-502
Open Access | Times Cited: 7
CRISPR-Cas knockout of miR21 reduces glioma growth
Lisa Nieland, Thomas S. van Solinge, Pike-See Cheah, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 121-136
Open Access | Times Cited: 26
MicroRNAs as the pivotal regulators of Temozolomide resistance in glioblastoma
Mahsa Palizkaran Yazdi, Amirhosein Barjasteh, Meysam Moghbeli
Molecular Brain (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Scrutinizing the landscape of DNA methylation epigenetic face(s) in glioblastomas
Nadia Μ. Hamdy, Mariam M. Gabr, Sherihan G. AbdelHamid, et al.
Elsevier eBooks (2024), pp. 467-504
Closed Access | Times Cited: 5
Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy
Dimitri Papukashvili, Nino Rcheulishvili, Cong Liu, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2957-2957
Open Access | Times Cited: 29
Plasma-Derived Exosome MiR-19b Acts as a Diagnostic Marker for Pancreatic Cancer
Lei Wang, Jinxiang Wu, Naikuan Ye, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 28
MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma
Botle Precious Setlai, Rodney Hull, Rui Manuel Reis, et al.
Genes (2022) Vol. 13, Iss. 2, pp. 244-244
Open Access | Times Cited: 20
Role of Circular RNA in Brain Tumor Development
Swalih P. Ahmed, Javier S. Castresana, Mehdi Hayat Shahi
Cells (2022) Vol. 11, Iss. 14, pp. 2130-2130
Open Access | Times Cited: 20
Potential utility of miRNAs for liquid biopsy in breast cancer
Xiangrong Liu, Dimitri Papukashvili, Zhixiang Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 20
MicroRNA biosensors for detection of glioblastoma
Mehdi Fattahi, Mohadese Maghsudlu, Masoumeh Razipour, et al.
Clinica Chimica Acta (2024) Vol. 556, pp. 117829-117829
Closed Access | Times Cited: 4
Anti-miRNA- 155 - 5p enhances the cytotoxic efficacy of temozolomide in brain cancer stem cells
Lütfiye Özpak, Bakiye Göker Bağca, Çığır Biray Avcı, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
A Comprehensive Review on LncRNAs/miRNAs‐DNMT1 Axis in Human Cancer: Mechanistic and Clinical Application
Seyed Mohsen Aghaei Zarch, Ali Esmaeili, Saeid Bagheri‐Mohammadi
Journal of Cellular and Molecular Medicine (2025) Vol. 29, Iss. 10
Open Access
ADAM17 Confers Temozolomide Resistance in Human Glioblastoma Cells and miR-145 Regulates Its Expression
Jen‐Tsung Yang, I‐Neng Lee, Cheng Huang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 7703-7703
Open Access | Times Cited: 9
Targeted therapies for Glioblastoma multiforme (GBM): State‐of‐the‐art and future prospects
S. Satish, Maithili Athavale, Prashant S. Kharkar
Drug Development Research (2024) Vol. 85, Iss. 7
Closed Access | Times Cited: 3
RGD Peptide Modified Erythrocyte Membrane/Porous Nanoparticles Loading Mir-137 for NIR-Stimulated Theranostics of Glioblastomas
Minghui Li, Xinyu Cui, Wei Feng, et al.
Nanomaterials (2022) Vol. 12, Iss. 9, pp. 1464-1464
Open Access | Times Cited: 12
Mesenchymal-Stem-Cell-Based Therapy against Gliomas
Sisa M. Santillán-Guaján, Mehdi Hayat Shahi, Javier S. Castresana
Cells (2024) Vol. 13, Iss. 7, pp. 617-617
Open Access | Times Cited: 2
The potential of miRNA-based approaches in glioblastoma: An update in current advances and future perspectives
Edgar G. Ordóñez-Rubiano, Nicolás Rincón-Arias, Sebastián Espinosa, et al.
Current Research in Pharmacology and Drug Discovery (2024) Vol. 7, pp. 100193-100193
Open Access | Times Cited: 2
Exploring miRNA therapies and gut microbiome–enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting
K. Sandhanam, Tamilanban Thamaraikani, Bedanta Bhattacharjee, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access | Times Cited: 2
New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs
Bianca O. Pîrlog, Silvina Iluț, Radu Pîrlog, et al.
Expert Reviews in Molecular Medicine (2023) Vol. 25
Closed Access | Times Cited: 5
Machine learning and bioinformatics approaches for classification and clinical detection of bevacizumab responsive glioblastoma subtypes based on miRNA expression
Jian Shi
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 9
miR-491-5p regulates the susceptibility of glioblastoma to ferroptosis through TP53
Xin-fang Jie, Yunpeng Li, Shuai Liu, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 671, pp. 309-317
Closed Access | Times Cited: 4
Therapeutic Effects of Exosomal miRNA-4731‐5p from Adipose Tissue-Derived Stem Cells on Human Glioblastoma Cells
Abouzar Babaei, Amin Torabi Yazdi, Reza Ranji, et al.
Archives of Medical Research (2024) Vol. 55, Iss. 7, pp. 103061-103061
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top